Molnupiravir
4482-023
Phase 3 small_molecule active
Quick answer
Molnupiravir for Coronavirus Disease (COVID-19) is a Phase 3 program (small_molecule) at Merck KGaA, Darmstadt, Germany with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Coronavirus Disease (COVID-19)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active